← Back to Search

Behavioral Intervention

AAC Technology for Child Hearing Loss

N/A
Recruiting
Led By Jareen Meinzen-Derr, PhD
Research Sponsored by Children's Hospital Medical Center, Cincinnati
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Currently receiving speech-language therapy
Documented permanent bilateral hearing loss with severity levels clinically defined in any range (mild to profound)
Must not have
Children with severe communication disorders (i.e. autism spectrum disorders)
Significant motor impairments
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change between baseline and 24 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial will test whether AAC technology can help improve language development in deaf or hard of hearing children.

Who is the study for?
This trial is for children with a language gap and documented permanent bilateral hearing loss of any severity who are already receiving speech-language therapy. It excludes those whose primary language isn't English, have significant motor impairments, nonverbal IQ below 60, or severe communication disorders like autism.
What is being tested?
The study tests if using augmentative and alternative communication (AAC) technology can improve language development in deaf or hard-of-hearing children. Participants will either receive AAC tech alongside their usual speech therapy or continue with their current care without the tech.
What are the potential side effects?
Since this trial involves educational technology rather than medication, traditional side effects aren't expected. However, there may be indirect effects on behavior or frustration levels due to adapting to new technologies.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am currently undergoing speech-language therapy.
Select...
I have permanent hearing loss in both ears.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
My child has a severe communication disorder like autism.
Select...
I have major difficulties with movement.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change between baseline and 24 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and change between baseline and 24 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Discourse
Syntax
semantics
Secondary study objectives
Language standard scores (receptive and expressive)
Social functioning

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Technology-assisted language interventionExperimental Treatment1 Intervention
This intervention will incorporate augmentative and alternative communication software delivered on iPads into speech-language therapy
Group II: usual careActive Control1 Intervention
This group will be usual care children are already receiving.

Find a Location

Who is running the clinical trial?

Children's Hospital Medical Center, CincinnatiLead Sponsor
836 Previous Clinical Trials
6,565,153 Total Patients Enrolled
3 Trials studying Hearing Loss
169 Patients Enrolled for Hearing Loss
Children's Hospital ColoradoOTHER
120 Previous Clinical Trials
5,133,037 Total Patients Enrolled
Jareen Meinzen-Derr, PhDPrincipal InvestigatorChildren's Hospital Medical Center, Cincinnati

Media Library

AAC Technology (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT02998164 — N/A
~13 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top